Hi I'm an allergist, too bad you can not rely on them for "testing". Agree with history as the most important test. Skin testing which assesses immediate hypersensitivity (IgE mediated) is of no help since reactions from RCM are non-IgE mediated. There is no skin testing for RCM, but thats why we are here to help when you need an answer.
Below is from Allergy and Immunology practice parameters Drug Allergy. This section deals with RCM.
Hope it is of some use.
B. Radiocontrast Media
Radiocontrast media containing organic iodine may cause adverse reactions such as generalized urticaria/angioedema, bronchospasm, laryngospasm, shock, and death. A review of 10,000 consecu- tive intravenous urograms reveals that the incidence of pseudoallergic reactions is 1.7%.154 The frequency of fatal reac- tions is 1 in 50,000 intravenous poly- gram procedures.155 These adverse reac- tions are not mediated by specific IgE antibodies. Only 16% of individuals with a previous immediate generalized reaction after intravenous injection of io- dinated radiographic compound respond with symptoms on the second chal- lenge.156 If these reactions had been me- diated by specific IgE, it would be ex- pected that a higher percentage of such patients would have experienced gener- alized reactions after the second chal- lenge dose. No single pathogenic mech- anism accounts for these unpredictable clinical manifestations but it is likely that mast cell activation accounts for the ma-
jority of these reactions. Activation of complement components has been de- scribed but not in all cases. Radiocon- trast media can also cause intravascular volume expansion and precipitate car- diogenic pulmonary edema in patients with ischemic cardiac heart disease.157
There is no evidence that sensitivity to seafood or iodine predisposes or is cross-reactive with RCM reactions. Al- though predictive tests are not available, patients with documented atopic profiles and those using beta blocking agents ap- pear to be at significant risk for RCM anaphylactoid reactions.158,159
Management of a patient who re- quires RCM and has had a prior reac- tion to RCM includes the following (1) determine if the study is essential; (2) determine that the patient under- stands the risks; (3) ensure proper hy- dration; (4) use a non-ionic, lower os- molar RCM, especially in high risk patients (asthmatic patients, patients on beta blockers and those with cardio- vascular disease)160 and (5) use a pre- treatment regimen which has been doc- umented to be successful in preventing most reactions.161 One reported regi- men consists of prednisone 50 mg (p.o.) 13, 7, and 1 hours before the procedure, diphenhydramine 50 mg one hour before the procedure and ei- ther ephedrine 25 mg or albuterol 4 mg 1 hour prior to the procedure. Some investigators prefer combining an H2 antagonist with the H1 antago- nist one hour before the procedure and omitting ephedrine or albuterol.